Katherine(Dillon)CameronMD

PubMed

• 11 citations
  A predictive model for chemotherapy-related diminished ovarian reserve in reproductive-age women
  Margaret Hopeman, Katherine E. Cameron, Maureen Prewitt, Kurt T. Barnhart, Jill P. Ginsberg, Mary D. Sammel, Clarisa R. Gracia> ;Fertility and Sterility. 2021 Feb 1
• Defining critical factors in multi-country studies of assisted reproductive technologies (ART): data from the US and UK health systems
  Michael L. Eisenberg, Barbara Luke, Katherine Cameron, Gary M. Shaw, Allan A. Pacey, Alastair G. Sutcliffe, C. Williams, Julian Gardiner, Richard A. Anderson, Valerie ...> ;Journal of Assisted Reproduction and Genetics. 2020 Sep 30
• 2 citations
  Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors
  Anat Chemerinski, Katherine E. Cameron, Mary D. Sammel, Jill P. Ginsberg, Claire A. Carlson, Clarisa R. Gracia> ;Journal of Cancer Survivorship. 2020 Apr 22
• 12 citations
  Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan
  Katherine E. Cameron, Mary D. Sammel, Maureen Prewitt, Clarisa R. Gracia> ;The Journal of Clinical Endocrinology and Metabolism. 2019 May 1
• 9 citations
  Acute Menopausal Symptoms in Young Cancer Survivors Immediately following Chemotherapy.
  Katherine E. Cameron, Martha B. Kole, Mary D. Sammel, Jill P. Ginsberg, Yasmin Gosiengfiao, Jennifer E. Mersereau, H. Irene Su, Clarisa R. Gracia> ;Oncology. 2018 Mar 1
• 36 citations
  Assessing reproductive choices of women and the likelihood of oocyte cryopreservation in the era of elective oocyte freezing
  Lauren W. Milman, Suneeta Senapati, Mary D. Sammel, Katherine D. Cameron, Clarisa R. Gracia> ;Fertility and Sterility. 2017 May 1
• 4 citations
  Following declining human chorionic gonadotropin values in pregnancies of unknown location: When is it safe to stop?
  Katherine E. Cameron, Suneeta Senapati, Mary D. Sammel, Karine Chung, Peter Takacs, Thomas A. Molinaro, Kurt T. Barnhart> ;Fertility and Sterility. 2016 Apr 1
• Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.
  Johnson LNC, Sammel MD, Dillon KE, Lechtenberg L, Schanne A, Gracia CR> ;Fertil. Steril.. 2014-09-01
• Response to ovarian stimulation in patients facing gonadotoxic therapy.
  Johnson LNC, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR> ;Reprod. Biomed. Online. 2013-04-01
• Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy.
  Dillon, K. E.,Sammel, M. D.,Prewitt, M.,Ginsberg, J. P.,Walker, D.,Mersereau, J. E.,Gosiengfiao, Y.,Gracia, C. R.> ;Fertil. Steril.. 2012 Oct 23
• How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity.
  Dillon, K. E.,Sioulas, V. D.,Sammel, M. D.,Chung, K.,Takacs, P.,Shaunik, A.,Barnhart, K. T.> ;Fertil. Steril.. 2012 Jul 17
• Sperm and oocyte cryopreservation: comprehensive consent and the protection of patient autonomy.
  Dillon, K. E.,Fiester, A. M.> ;Hum. Reprod.. 2012 Aug 14
• Pediatric and young adult patients and oncofertility.
  Dillon, K. E.,Gracia, C. R.> ;Curr Treat Options Oncol. 2012 Mar 17
• Join now to see all